Our aims were to comprehensively analyze genomic changes in Chinese GISTs and to identify rare novel gene mutations in KIT/PDGFRA or other tumor-related genes that may take part in the development and chemoresistance of GIST from an omics viewpoint. The gene discussed is KIT; the disease is neoplasm.